Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels
SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data.
Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO
The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.
$64M raised for new cardiogenic shock drug—research already underway
Procizumab was developed to change the trajectory of shock by addressing an underlying molecular driver rather than just managing symptoms.
Prosthesis-patient mismatch after TAVR may not negatively impact quality of life
Researchers warned that “aggressive procedural modifications” should not be necessary during TAVR to mitigate the risk of prosthesis-patient mismatch. This appears to be true for patients receiving both self-expanding and balloon-expandable TAVR valves.
SCAI fighting for interventional cardiologists amid challenging payment policies
SCAI President Srihari Naidu, MD, detailed some of the challenges interventional cardiologists face as reimbursements keep declining. The group has been building new partnerships with other medical societies to strengthen its influence in Washington.

CroíValve kicks off early feasibility study for new TR device, names cardiologist Martin Leon to advisory board

The company hopes to enroll 15 patients to monitor the safety and effectiveness of its new-look transcatheter device for severe tricuspid regurgitation.

Tootsie Roll paravalvular leak transcatheter heart valves

New ‘Tootsie Roll’ technique could help cardiologists treat PVL in transcatheter heart valves

Paravalvular leak remains a significant problem after TAVR, SAVR and even TMVR. Could a new-look interventional technique help heart teams overcome this issue and improve patient outcomes?

Medicare data stethoscope healthcare trends graphs finance financials

An updated look at combining LAAO with ablation, TAVR or other interventional heart procedures

Performing two procedures at once does not appear to make a significant impact on patient safety, though it may lead to a few new risks sure to interest heart teams.

FDA grants new valve-in-valve TAVR offering its breakthrough device designation

The new device was designed to help clinicians perform valve-in-valve TAVR on certain high-risk patients. One cardiologist familiar with the technology said it could be easily added to any preexisting TAVR workflow.

Samin Sharma, MD, director of interventional cardiology and director of clinical cardiology, Mount Sinai Hospital, New York, discusses the first-in-human use of the Magenta Elevate percutaneous left ventricular assist device (pLVAD) with a small 10 French size and 5.5 liters per minute of hemodynamic support.

Initial results promising for world's smallest percutaneous heart pump

A new 10 French percutaneous heart pump could help greatly reduce vascular complications and improve cardiogenic shock outcomes.

older patient with a doctor at their house

Valve-in-valve TAVR with Medtronic’s CoreValve devices still safe and effective after 5 years

Researchers tracked five-year data from more than 200 patients, sharing their findings in the American Journal of Cardiology.

Preventing blood clots after TMVR—what is the best anticoagulant for the job?

Choosing between DOACs and VKAs could make a significant impact on patient outcomes, according to new findings published in the Journal of the American College of Cardiology.

Bleeding after PCI remains a significant issue for interventional cardiologists around the world

A new meta-analysis included data from nearly 400,000 PCI patients treated in the United States, Germany, Japan or Israel.

Interventional Cardiology

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels

Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO

$64M raised for new cardiogenic shock drug—research already underway

Prosthesis-patient mismatch after TAVR may not negatively impact quality of life

SCAI fighting for interventional cardiologists amid challenging payment policies